MedixMedix Inc.331A東証スタンダードサービス業FY ending Mar 2026, consolidated, J-GAAP
Medix brought in ¥4.16B in revenue.
Out of every ¥100 of sales, about ¥19 is left as operating profit.
Revenue changed -0.4% from the prior year, operating profit +0.1%.
Revenue -0.4% · profit +0.1%, calculated from disclosed figures.
Operating leverage: -0.27× (profit growth ÷ revenue growth)
FY ending Mar 2024 → FY ending Mar 2025
FY ending Mar 2024 → FY ending Mar 2025
For every ¥100 Medix sells, how much goes where, and how much is kept.
Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.
EDINET (FSA Japan)
有価証券報告書－第42期(2024/04/01－2025/03/31)
Extracted from XBRL: 46 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.